1. Tominaga T, Asahina Y, Uyama Y, Kondo T. Regulatory science as a bridge between science and society. Clin Pharmacol Ther. 2011;90(1):29–31.
2. Pharmaceuticals and Medical Devices Agency. Profile of services 2011–2012. Available at: http://www.pmda.go.jp/english/about/pdf/profile_of_services.pdf. Accessed August 20, 2012.
3. Mori K, Toyoshima S. Recent approaches by the PMDA to promoting new drug development: change in the status of the PMDA in relation to new drug development over the last five years. Drug Inf J. 2009;43(1):47–55.
4. Pharmaceuticals and Medical Devices Agency. Pharmacovigilance activities in Japan (presented by Hori A). Available at: http://www.pmda.go.jp/regulatory/file/english_presentation/safety/S-E2hori.pdf. Accessed September 6, 2012.
5. Pharmaceuticals and Medical Devices Agency. Relief service for adverse health effects in Japan (presented by Miyazaki S). Available at: http://www.pmda.go.jp/regulatory/file/english_presentation/relief_funds/RF-E1miyazaki.pdf. Accessed September 6, 2012.